When she was diagnosed with the injury of Nélida Evaldi Borm in the breast, she was panic-stricken by what was coming and her fantasy was clouded by expectations of a long and painful treatment. But after undergoing a cryotherapy to freeze the tumor, she was quickly surprised by the painless healing.
“It’s amazing,” said the 79-year-old woman. My tongue is unable to express how relieved I am that they have not been forced to do an autopsy. The worst nightmare for me was having to be removed anywhere, especially my breasts. ” “It did not hurt me, it did not cause me the slightest inconvenience,” she said, speaking to Dr. Andrew Kenler, who treated her at his clinic in Trimble, Conn.
Evaldi, a retired schoolteacher, has participated in clinical trials of new treatments that allow the removal of some breast tumors during a 20 to 30 minute session in a simple procedure involving the minimal intervention created by the Israeli company IceCure.
This procedure involves the insertion of a metal part that can be compared to the endoscopic in the breast where it will freeze the target tissue only, without compromising healthy tissue. This procedure leaves only a small scar that heals and heal within days.
The procedure requires only an ultrasound device, an ice-cure device and local anesthesia. So it can be done in any clean room. The patient will be able to return to normal life once the treatment has been completed.
“This is a complete revolution,” says Elisabeth Sadka, vice president of quality assurance at Ice Cure in an interview at the company’s offices in Caesarea. “It would be a better solution for tumors, otherwise it would be expensive surgery to leave patients suffering from the pain, scars and surgery that will last a lifetime.”
“From the start, there is a company that says: breast cancer, some breast cancers, certain breast cancer, can be treated without surgery, minimal intervention (inside the body) is very similar to a telescope.”
Sadka explained that the criteria for treatment with Ice Cure are related to the stage, size and shape of the tumor. In the case of breast cancer it must be in the first or second stage, and be a solid tumor not more than 1.5 centimeters.
In October 2018, the American Society of Breast Surgeons updated its guidelines to recommend that surgeons participate in clinical trials to treat malignant breast tumors. This came after the publication of the results of Ice Cure on the latest clinical trials on 146 patients in 18 leading US hospitals and clinics in May, without recurrence of the tumor only in one case.
In Japan, more than 200 women participated in clinical trials that showed recurrence in less than 1% of cases over three to five years of follow-up. In light of these results, the company says that the technology of oncology at refrigeration achieves at least the same level of success as current treatments, and perhaps even better.
Eyal Shamir, Executive Director of Ice Cure, said that recent publications have increased interest in Ice Cure in the medical community, as well as among patients.
Shamir added that the market for such treatment could reach $ 800 million in 2018 and is expected to be worth about $ 2 billion by 2025. The treatment of Ice Cure costs about $ 4,000, which is about one third of the cost of breast surgery, Means a significant reduction in cost relative to the benefits to patients. The treatment is available to patients outside clinical trials in Israel, the United States, Japan, Mexico and many European countries.
“Portable ultrasound and our device, you can go anywhere in Africa, India, China and other third world countries, where you can not have surgery here,” he said. Shamir hopes that the treatment will be available in the future further and be applicable to other types of tumors.